Bayesian Capital Management, LP Laboratory Corp Of America Holdings Transaction History

Bayesian Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $409,620 - $524,380	-2,000 Reduced 27.78%	5,200 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $1.24 Million - $1.61 Million	5,800 Added 414.29%	7,200 $1.69 Million
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $162,647 - $186,660	626 Added 80.88%	1,400 $369,000
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $278,661 - $322,379	-1,026 Reduced 57.0%	774 $243,000
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $494,676 - $555,012	1,800 New	1,800 $507,000
Q2 2021 Aug 13, 2021	SELL	$251.87 - $278.14 $268,493 - $296,497	-1,066 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$204.88 - $255.03 $218,402 - $271,861	1,066 New	1,066 $272,000
Q2 2019 Aug 13, 2019	SELL	$144.16 - $172.9 $360,400 - $432,250	-2,500 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $309,250 - $390,750	2,500 New	2,500 $382,000
Q4 2017 Feb 12, 2018	SELL	$147.99 - $163.95 $2.18 Million - $2.41 Million	-14,700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$149.47 - $160.56 $2.2 Million - $2.36 Million	14,700	14,700 $2.22 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.